Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab

Int Immunopharmacol. 2010 Jul;10(7):827-8. doi: 10.1016/j.intimp.2010.04.016. Epub 2010 Apr 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Viral / blood
  • Antigens, Neoplasm / immunology
  • Arthritis, Psoriatic / blood
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / diagnosis
  • Arthritis, Psoriatic / drug therapy*
  • Early Detection of Cancer
  • Herpesvirus 8, Human / immunology*
  • Herpesvirus 8, Human / pathogenicity
  • Humans
  • Immunohistochemistry
  • Infliximab
  • Male
  • Middle Aged
  • Monitoring, Physiologic
  • Sarcoma, Kaposi / blood
  • Sarcoma, Kaposi / complications
  • Sarcoma, Kaposi / diagnosis
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / etiology
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Skin / virology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Viral Proteins / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Antigens, Neoplasm
  • Tumor Necrosis Factor-alpha
  • Viral Proteins
  • Infliximab